Phase I trial of hu3S193 in patients with advanced epithelial cancers which express the Lewis-y antigen

2004 ◽  
Vol 22 (14_suppl) ◽  
pp. 2567-2567
Author(s):  
A. M. Scott ◽  
N. Tebbutt ◽  
F.-T. Lee ◽  
T. Cavicchiolo ◽  
Z. Liu ◽  
...  
Keyword(s):  
Phase I ◽  
Phase I Trial ◽  
Epithelial Cancers ◽  
Lewis Y Antigen ◽  
Lewis Y

Phase I trial of hu3S193 in patients with advanced epithelial cancers which express the Lewis-y antigen

2004 ◽  
Vol 22 (14_suppl) ◽  
pp. 2567-2567 ◽  
Author(s):  
A. M. Scott ◽  
N. Tebbutt ◽  
F.-T. Lee ◽  
T. Cavicchiolo ◽  
Z. Liu ◽  
...  
Keyword(s):  
Phase I ◽  
Phase I Trial ◽  
Epithelial Cancers ◽  
Lewis Y Antigen ◽  
Lewis Y

A Phase I Trial of a Monoclonal Antibody Directed to Lewis Y

2004 ◽  
Vol 27 (6) ◽  
pp. S10
Author(s):  
D Oruzio ◽  
G Schlimok ◽  
N Eller ◽  
C Aulmann ◽  
S Stranner ◽  
...  
Keyword(s):  
Monoclonal Antibody ◽  
Phase I ◽  
Phase I Trial ◽  
Lewis Y

A Phase I Trial of a 3-Day Topotecan Q 21 Days for Recurrent Epithelial Cancers of the Ovary, Fallopian Tube, and Peritoneum

2000 ◽  
Vol 79 (3) ◽  
pp. 495-498 ◽  
Author(s):  
John V. Brown ◽  
William A. Peters ◽  
Mark A. Rettenmaier ◽  
Beth Y. Karlan ◽  
Robert A. Dillman ◽  
...  
Keyword(s):  
Phase I ◽  
Fallopian Tube ◽  
Phase I Trial ◽  
Epithelial Cancers

scholarly journals Chemoresistance Is Associated with MUC1 and Lewis y Antigen Expression in Ovarian Epithelial Cancers

2013 ◽  
Vol 14 (6) ◽  
pp. 11024-11033 ◽  
Author(s):  
Danye Zhang ◽  
Jian Gao ◽  
Liancheng Zhu ◽  
Zhenhua Hu ◽  
Rui Hou ◽  
...  
Keyword(s):  
Antigen Expression ◽  
Epithelial Cancers ◽  
Lewis Y Antigen ◽  
Lewis Y

scholarly journals Phase I Biodistribution and Pharmacokinetic Study of Lewis Y-Targeting Immunoconjugate CMD-193 in Patients with Advanced Epithelial Cancers

2009 ◽  
Vol 15 (21) ◽  
pp. 6709-6715 ◽  
Author(s):  
R. A. Herbertson ◽  
N. C. Tebbutt ◽  
F.-T. Lee ◽  
D. J. MacFarlane ◽  
B. Chappell ◽  
...  
Keyword(s):  
Phase I ◽  
Pharmacokinetic Study ◽  
Epithelial Cancers ◽  
Lewis Y

604: A Phase I Trial of Vaccination of Personalized Peptides for HLA-A2/A24 Positive Patients with Hormone-Refractory Prostate Cancer

2007 ◽  
Vol 177 (4S) ◽  
pp. 202-202
Author(s):  
Hirotsugu Uemura ◽  
Motoyoshi Tanaka ◽  
Shigeya Uejima ◽  
Takafumi Minami ◽  
Kiyohide Fujimoto ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Phase I ◽  
Phase I Trial ◽  
Hormone Refractory Prostate Cancer ◽  
Hormone Refractory
Sign in / Sign up

Export Citation Format

Share Document